Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

1,042 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.
Xue BZ, Xiang W, Zhang Q, Wang HF, Zhou YJ, Tian H, Abdelmaksou A, Xue J, Sun MX, Yi DY, Xiong NX, Jiang XB, Zhao HY, Fu P. Xue BZ, et al. Among authors: zhou yj. Stem Cell Res Ther. 2021 Jul 13;12(1):394. doi: 10.1186/s13287-021-02458-8. Stem Cell Res Ther. 2021. PMID: 34256854 Free PMC article.
Correction to: CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells.
Xue BZ, Xiang W, Zhang Q, Wang HF, Zhou YJ, Tian H, Abdelmaksou A, Xue J, Sun MX, Yi DY, Xiong NX, Jiang XB, Zhao HY, Fu P. Xue BZ, et al. Among authors: zhou yj. Stem Cell Res Ther. 2021 Sep 6;12(1):493. doi: 10.1186/s13287-021-02566-5. Stem Cell Res Ther. 2021. PMID: 34488861 Free PMC article. No abstract available.
1,042 results